RxDoctor Payments Data

Robert Allen, MD

Family Medicine · Visalia, CANPI 1629074489

Payments from drug & device makers

$958in general payments, 2019–2025

Across 52 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$330
  • Eko Health, Inc.$200
  • Amgen$114
  • AbbVie$75
  • Merck$59
  • Lilly USA, LLC$42
  • plus $137 from 7 others

What the payments were for

  • Speaking & faculty fees$20021%
  • Food & beverage$73477%
  • Education$243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$958 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$897,106
Medicare patients
6,101
Services billed
74,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol59$66,417
OzempicSemaglutide39$47,671
EliquisApixaban32$45,324
JardianceEmpagliflozin46$38,212
MyrbetriqMirabegron23$13,759
JanumetSitagliptin Phos/Metformin Hcl14$12,545
Atorvastatin Calcium1,125$8,904
Tresiba Flextouch U-100Insulin Degludec12$8,185
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$5,351
Levothyroxine Sodium481$5,209
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$4,116
Repaglinide52$3,394
Losartan Potassium345$2,675
Tamsulosin Hcl163$2,216
Gabapentin124$2,170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$330$66,41759 claims
PfizerEliquis$16$45,32432 claims
Boehringer IngelheimJardiance$18$38,21246 claims
MerckJanumet$59$12,54514 claims
AbbVieSynthroid$75$1,70926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,533 family medicine providers in California.

Other family medicine in Visalia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →